The Ongoing Debate Over Kratom and 7-OH Products

December 29, 2025 - 16:36

Kratom and 7-OH products have become increasingly accessible in numerous smoke shops across the country. However, their availability has sparked significant public health discussions. Earlier this year, the FDA took a notable step by recommending that certain 7-OH products be classified alongside opioids, raising concerns about their safety and potential for abuse.

This is not the first time kratom has faced scrutiny. Nearly a decade ago, the DEA attempted to classify certain active ingredients in kratom as controlled substances, which would have drastically limited their availability. The proposal met with widespread public outcry, leading the DEA to abandon its plans.

Now, as the FDA revisits the issue, experts are weighing in on the implications of these recommendations. Producer Rachel Carlson recently discussed the potential outcomes and the current scientific understanding of kratom and 7-OH with host Emily Kwong. The conversation highlights the ongoing uncertainty surrounding these substances and the need for further research to assess their risks and benefits.